Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -21.58%-1.54M | 45.02%-879.7K | -3.45%-5.52M | 47.12%-950.63K | -60.04%-1.7M | -14.71%-1.27M | -16.87%-1.6M | 84.74%-5.33M | 81.30%-1.8M | 91.43%-1.06M |
| Net income from continuing operations | -1.37%-1.65M | -38.00%-1.56M | 89.23%-2.28M | 107.60%1.4M | 17.04%-913.23K | -69.16%-1.63M | -57.10%-1.13M | 42.30%-21.14M | -1,670.93%-18.35M | 94.50%-1.1M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 88.70%-261.72K | -163.73%-498.67K | 135.83%166.22K |
| Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --17.39M | ---- | ---- |
| Remuneration paid in stock | --268.86K | --141.07K | 346.10%426.9K | --426.9K | --0 | --0 | --0 | -96.78%95.7K | --0 | --0 |
| Other non cashItems | ---- | ---- | ---3.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -142.71%-155.63K | 212.99%534.53K | 80.91%-271.93K | 283.93%622.93K | -518.00%-786.2K | 225.36%364.44K | 29.16%-473.09K | -238.64%-1.42M | 96.29%-338.68K | -101.67%-127.22K |
| -Change in receivables | -629.73%-32.37K | -59.28%19.03K | -103.23%-47.97K | -340.70%-77.84K | -112.84%-12.43K | -100.33%-4.44K | 1,081.74%46.73K | 217.36%1.49M | 100.35%32.34K | -98.91%96.84K |
| -Change in payables and accrued expense | -187.63%-157.26K | 192.09%342.68K | 100.49%15.24K | 247.48%349.48K | -54.37%-141.57K | 110.20%179.46K | 64.40%-372.13K | -226.13%-3.13M | 98.14%-236.97K | -100.67%-91.71K |
| -Change in other working capital | -82.05%34K | 217.01%172.82K | -207.07%-239.19K | 362.06%351.29K | -377.67%-632.2K | 76.16%189.41K | -138.64%-147.69K | 216.95%223.4K | -101.04%-134.05K | 99.12%-132.35K |
| Cash from discontinued investing activities | 0 | |||||||||
| Operating cash flow | -21.58%-1.54M | 45.02%-879.7K | -3.45%-5.52M | 47.12%-950.63K | -60.04%-1.7M | -14.71%-1.27M | -16.87%-1.6M | 85.10%-5.33M | 81.36%-1.8M | 91.24%-1.06M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -99.98%1.67K | -52.53%-228.79K | 68.28%7.24M | -115.48%-386.96K | 74.22%-180.45K | 218.14%7.95M | -150K | 375.73%4.3M | 260.58%2.5M | -26,335.05%-700K |
| Net PPE purchase and sale | -97.24%225K | -50.00%-225K | 48.85%7.44M | -115.69%-392.29K | ---180.45K | 226.61%8.17M | ---150K | 412.70%5M | 256.35%2.5M | --0 |
| Net business purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---700K | --0 | ---- |
| Net investment property transactions | ---- | ---- | ---150K | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
| Net investment purchase and sale | 102.69%1.67K | ---3.79K | ---56.57K | --5.32K | --0 | ---61.89K | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | 0 | |||||||||
| Investing cash flow | -99.98%1.67K | -52.53%-228.79K | 68.28%7.24M | -115.48%-386.96K | 74.22%-180.45K | 218.14%7.95M | ---150K | 353.47%4.3M | 328.01%2.5M | -134.24%-700K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | |||||||||
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 203.78%3.6M | 59.29%4.73M | -27.82%2.97M | 175.20%6.03M | 106.37%7.95M | -51.55%1.19M | -27.82%2.97M | 19.54%4.11M | -84.85%2.19M | -84.34%3.85M |
| Current changes in cash | -123.03%-1.54M | 36.66%-1.11M | 266.14%1.72M | -290.43%-1.34M | -6.70%-1.88M | 379.35%6.69M | -27.82%-1.75M | -225.96%-1.03M | 106.54%702.41K | 82.63%-1.76M |
| Effect of exchange rate changes | -101.30%-984 | 44.76%-17.53K | 137.63%41.3K | -51.59%35.94K | -137.86%-38.53K | 663.83%75.63K | 89.27%-31.74K | 26.33%-109.76K | -80.83%74.24K | 505.68%101.78K |
| End cash Position | -74.09%2.06M | 203.78%3.6M | 59.29%4.73M | 59.29%4.73M | 175.20%6.03M | 106.37%7.95M | -51.55%1.19M | -27.82%2.97M | -27.82%2.97M | -84.85%2.19M |
| Free cash from | -17.77%-1.32M | 36.88%-1.1M | -3.45%-5.52M | 47.12%-950.63K | -60.04%-1.7M | -1.14%-1.12M | -27.82%-1.75M | 85.74%-5.33M | 84.01%-1.8M | 91.24%-1.06M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.